Clinical Trial Update: Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing etanercept and Enbrel for rheumatoid arthritis, focusing on efficacy, safety, and immunogenicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• Etanercept (etanercept)

Snippet

Sponsor: Joint Stock Company "Farmak" | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN